Seriously Don’t Do That™
Seriously Don’t Do That™ is a weekly show for founders making high-stakes growth decisions and trying not to learn the hard way.
Each episode focuses on one specific mistake founders make under pressure: U.S. market entry assumptions, emotional beachhead choices, premature sales hires, ICP chaos, compliance blind spots, broken pipelines, and board-level credibility gaps.
Hosted by Dan Griffith, the show brings pattern recognition from real founder situations across healthcare, fintech, insurance, and other regulated or institutionally complex markets. Guest episodes validate the reality. Dan explains what actually went wrong and what to do instead.
This isn’t hustle content. It’s not tactics without context. And it’s not agency advice.If growth feels harder than it should… you’re probably right.
Seriously, Don’t Do That!
Seriously Don’t Do That™
Who Really Signs the Check? Selling Healthtech in the U.S. Market
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Most founders don’t lose U.S. deals because of their product…
they lose because they pitch to the wrong person.
And that’s exactly what we’re breaking down live this week.
If you're building or selling in healthtech and you still assume the clinician is the buyer… you’re already behind.
Because the people who love your product?
They’re rarely the people who sign the contract.
This session is the wake-up call most European teams don’t get until they’ve burned years of budget, time, and trust.
We’re going deep into:
• Who actually controls healthcare budgets in the U.S.
• Why FDA clearance opens doors but ROI closes deals
• How payers, employers, and providers think — and what moves them
• The one question that decides whether you’re ready to sell here
If you’re not in the room, you’ll spend the next 12–18 months learning this the hard way.
→ Don’t miss it. This conversation can save you years.
